I am a hematologist with a special interest in the treatment of multiple myeloma and immunotherapy. My clinical research focuses on combining current treatments for myeloma (including those now in clinical trials) with immunotherapy. This makes sense because our current treatments and those treatments that are now in clinical trials often wipe out most or all measurable disease, but any residual disease can lead to relapse. The goal of immunotherapy is to target this residual disease and eliminate it, preventing relapse.
years treating myeloma:
Number of Myeloma Patients Treated Annually:
Details & contact info
York Avenue Manhattan
New York City, NY, United States, 10128
Send a message to Nikoletta Lendvai, MD, PHD